For patients newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), it's essential to set realistic expectations and prioritize whole-person care. Dr. Joban Vaishnav, Assistant Professor of Medicine and Director of the Comprehensive Amyloidosis Center at Johns Hopkins Medicine, shares insights on guiding these patients through this diagnosis.